TDI-132 Shows Promising Results In the Treatment of ALS

ALS may be the most dead­ly dis­ease many peo­ple have nev­er heard of. Amy­otroph­ic lat­er­al scle­ro­sis (ALS), also referred to as Lou Gehrig’s dis­ease affects at least 30,000 peo­ple in the Unit­ed States and 450,000 peo­ple world­wide.  It is a pro­gres­sive neu­rode­gen­er­a­tive dis­or­der that caus­es mus­cle atro­phy, paral­y­sis, and ulti­mate­ly death with a three to five year sur­vival rate. …Read more at Onemedplace.com